Zobrazeno 1 - 10
of 203
pro vyhledávání: '"Cazaubiel T"'
Autor:
Schavgoulidze A; Myeloma Genomic Lab, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Corre J; Myeloma Genomic Lab, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Samur MK; Dana Farber Cancer Institute, Boston, MA., Mazzotti C; Myeloma Genomic Lab, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Pavageau L; Myeloma Genomic Lab, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Perrot A; Hematology Department, IUCT-Oncopole, Toulouse, France., Cazaubiel T; Hematology Department, University Hospital, Bordeaux, France., Leleu X; Hematology Department, University Hospital, Poitiers, France., Macro M; Hematology Department, University Hospital, Caen, France., Belhadj K; Hematology Department, University Hospital, Creteil, France., Roussel M; Hematology Department, University Hospital, Limoges, France., Brechignac S; Hematology Department, University Hospital, Bobigny, France., Montes L; Hematology Department, University Hospital, Amiens, France., Caillot D; Hematology Department, University Hospital, Dijon, France., Frenzel L; Hematology Department, University Hospital, Paris, France., Rey P; Hematology Department, Centre Leon Berard, Lyon, France., Schiano de Colella JM; Hematology Department, Institut Paoli Calmette, Marseille, France., Chalopin T; Hematology Department, University Hospital, Tours, France., Jacquet C; Hematology Department, University Hospital, Nancy, France., Richez V; Hematology Department, University Hospital, Nice, France., Orsini-Piocelle F; Hematology Department, General Hospital, Annecy, France., Fontan J; Hematology Department, General Hospital, Besancon, France., Manier S; Hematology Department, University Hospital, Lille, France., Martinet L; Myeloma Genomic Lab, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Sciambi A; Mission Bio, South San Francisco, CA., Mohty M; Hematology Department, University Hospital, Paris, France., Avet-Loiseau H; Myeloma Genomic Lab, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
Publikováno v:
Blood [Blood] 2024 Jul 11; Vol. 144 (2), pp. 201-205.
Autor:
Jourdes A; Service de Maladies Infectieuses et Tropicales, Centre Hospitalo-universitaire (CHU) de Toulouse, France., Cellerin E; Service d'hématologie, Centre Hospitalo-universitaire (CHU) de Tours, France., Touzeau C; Service d'hématologie, Centre Hospitalo-universitaire (CHU) Hôtel Dieu, Nantes, France., Harel S; Service d'immuno-hématologie, Hôpital St-Louis, AP-HP, Paris, France., Denis B; Service de Maladies Infectieuses et Tropicales, Hôpital St-Louis, AP-HP, Paris, France., Escure G; Service d'hématologie, Centre Hospitalo-universitaire (CHU) de Lille, France., Faure E; Service d'hématologie, Centre Hospitalo-universitaire (CHU) de Lille, France; U1019-UMR 9017-Centre d'Infection et d'Immunité de Lille, INSERM, Centre National de la Recherche Scientifique, Institut Pasteur de Lille, Université de Lille, Lille, France., Jamard S; Service de Médecine Infectieuse et Tropicale, Centre Hospitalo-Universitaire (CHU) de Tours, France., Danion F; Service de Maladies Infectieuses et Tropicales, Les Hôpitaux Universitaires de Strasbourg, Strasbourg, Grand Est, France; Laboratoire d'Immuno-rhumatologie Moléculaire UMR_S 1109, INSERM, Strasbourg, Grand Est, France., Sonntag C; Service d'hématologie, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France., Ader F; Département des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France; Centre International de Recherche en Infectiologie (CIRI), INSERM 1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, École Normale Supérieure de Lyon, Univ Lyon, Lyon, France., Karlin L; Service d'hématologie, Centre Hospitalier Lyon-Sud, Lyon, France., Soueges S; Département des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France., Cazelles C; Service d'hématologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Institut Cochin, Université de Paris, CNRS UMR8104, INSERM U1016, Paris, France., de La Porte des Vaux C; Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, AP-HP, Paris, France., Frenzel L; Service d'hématologie, Hôpital Necker-Enfants Malades, AP-HP, Paris, France; CEREMAST, Institut Imagine, INSERM U1163, AP-HP, Hôpital Necker-Enfants Malades, Université Paris Centre, Paris, France., Lanternier F; Service de Maladies Infectieuses et Tropicales, Hôpital Necker-Enfants Malades, AP-HP, Paris, France; Institut Pasteur, Université Paris Cité, Centre National de Référence Mycoses Invasives et Antifongiques, Groupe de Recherche Translationnelle en Mycologie, Département de Mycologie, Paris, Île-de-France, France., Brousse X; Service de Maladies Infectieuses et Tropicales, Centre Hospitalo-universitaire (CHU) de Bordeaux, France., Cazaubiel T; Service d'hématologie, Centre Hospitalo-universitaire (CHU) de Bordeaux, France; Equipe Génomique et Immunologie du Myélome Multiple, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Université Paul Sabatier, Toulouse, France., Berger P; Infectiologie Transversale, Institut Paoli-Calmettes, Marseille, France., Collignon A; Service d'hématologie, Institut Paoli-Calmettes, Marseille, France., Blot M; Service de Maladies Infectieuses et Tropicales, Centre Hospitalo-universitaire (CHU) de Dijon-Bourgogne, France; INSERM, Université de Bourgogne, CIC 1432, Module Épidémiologie Clinique, Dijon, France; Equipe Lipness, INSERM LNC-UMR1231 et LabEx LipSTIC, Université de Burgundy, Dijon, France., Pieragostini A; Service d'hématologie, Centre Hospitalo-universitaire (CHU) de Dijon-Bourgogne, France., Charles M; Service de Maladies Infectieuses et Tropicales, Centre Hospitalo-universitaire (CHU) d'Estaing, Clermont-Ferrand, France., Chaleteix C; Service d'hématologie, Centre Hospitalo-universitaire (CHU) d'Estaing, Clermont-Ferrand, France., Redor A; Service de Maladies Infectieuses et Tropicales, Centre Hospitalier de Perpignan, France., Roland V; Service d'hématologie, Centre Hospitalier de Perpignan, France., Cartau T; Service de Maladies Infectieuses et Tropicales, Centre Hospitalo-universitaire (CHU) Côte de Nacre, Caen, France., Macro M; Service d'hématologie, Institut bas Normand d'Hématologie, CHU Caen Normandie, Caen, France., Chalopin T; Service d'hématologie, Centre Hospitalo-universitaire (CHU) de Tours, France., Vallet N; Service d'hématologie, Centre Hospitalo-universitaire (CHU) de Tours, France; Equipe INSERM U1069 N2COx, Groupe LNOx, Université de Tours, France., Perrot A; Service de Maladies Infectieuses et Tropicales, Centre Hospitalo-universitaire (CHU) de Bordeaux, France; Service d'hématologie, Centre Hospitalo-universitaire (CHU) de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-O), Toulouse, France., Martin-Blondel G; Service de Maladies Infectieuses et Tropicales, Centre Hospitalo-universitaire (CHU) de Toulouse, France; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity) INSERM, Université Toulouse III, Toulouse, France. Electronic address: martin-blondel.g@chu-toulouse.fr.
Publikováno v:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2024 Jun; Vol. 30 (6), pp. 764-771. Date of Electronic Publication: 2024 Mar 01.
Autor:
Schavgoulidze A; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Perrot A; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France.; Hematology Department, IUCT-Oncopole, Toulouse, France., Cazaubiel T; Hematology Department, University Hospital, Bordeaux, France., Leleu X; Hematology Department, University Hospital, Poitiers, France., Montes L; Hematology Department, University Hospital, Amiens, France., Jacquet C; Hematology Department, University Hospital, Nancy, France., Belhadj K; Hematology Department, University Hospital, Créteil, France., Brechignac S; Hematology Department, University Hospital, Bobigny, France., Frenzel L; Hematology Department, Necker University Hospital, Paris, France., Chalopin T; Hematology Department, University Hospital, Tours, France., Rey P; Hematology Department, Centre Léon Bérard, Lyon, France., Schiano de Collela JM; Hematology Department, Institut Paoli Calmettes, Marseille, France., Dib M; Hematology Department, University Hospital, Angers, France., Caillot D; Hematology Department, Institut de Cancérologie de Bourgogne, Dijon, France., Macro M; Hematology Department, University Hospital, Caen, France., Fontan J; Hematology Department, University Hospital, Besançon, France., Buisson L; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Pavageau L; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Roussel M; Hematology Department, University Hospital, Limoges, France., Manier S; Hematology Department, University Hospital, Lille, France., Mohty M; Hematology Department, Saint-Antoine University Hospital, Paris, France., Martinet L; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Avet-Loiseau H; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France., Corre J; Unit for Genomics in Myeloma, University Hospital IUCT-Oncopole, Toulouse, France. corre.jill@iuct-oncopole.fr.; Cancer Research Center of Toulouse (CRCT), Institut National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Université Toulouse III-Paul Sabatier (UPS), Toulouse, France. corre.jill@iuct-oncopole.fr.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Oct 26; Vol. 13 (1), pp. 160. Date of Electronic Publication: 2023 Oct 26.
Autor:
Schavgoulidze A; Institut Universitaire du Cancer de Toulouse-Oncopole and Centre de Recherches en Cancerologie de Toulouse Institut National de la Sante et de la Recherche Medicale, Toulouse., Lauwers-Cances V; Centre Hospitalier Universitaire Toulouse, Toulouse., Perrot A; Institut Universitaire du Cancer de Toulouse-Oncopole and Centre de Recherches en Cancerologie de Toulouse Institut National de la Sante et de la Recherche Medicale, Toulouse., Cazaubiel T; Centre Hospitalier Universitaire Bordeaux, Bordeaux., Chretien ML; Centre Hospitalier Universitaire Dijon, Dijon., Moreau P; Centre Hospitalier Universitaire Nantes, Nantes., Facon T; Centre Hospitalier Universitaire Lille, Lille., Leleu X; Centre Hospitalier Universitaire Poitiers, Poitiers., Karlin L; Centre Hospitalier Universitaire Lyon, Lyon., Stoppa AM; Institut Paoli Calmettes, Marseille., Decaux O; Centre Hospitalier Universitaire Rennes, Rennes., Belhadj K; Centre Hospitalier Universitaire Creteil, Creteil., Arnulf B; Centre Hospitalier Universitaire, Hopital Saint Louis, Paris., Mohty M; Centre Hospitalier Universitaire, Hopital Saint-Antoine, Paris., Ariette CM; Centre Hospitalier Universitaire Grenoble Alpes, Grenoble., Fohrer-Sonntag C; Centre Hospitalier Universitaire Hautepierre, Strasbourg., Lenain P; Centre de Lutte Contre le Cancer - Centre Henri Becquerel, Rouen., Marolleau JP; Centre Hospitalier Universitaire Amiens, Amiens., Tiab M; Centre Hospitalier Departemental Vendee, La Roche-sur-Yon., Araujo C; Centre Hospitalier de la Cote Basque, Bayonne., Orsini-Piocelle F; Centre Hospitalier Annecy Genevois, Metz-Tessy., Jaccard A; Centre Hospitalier Universitaire Limoges, Limoges., Roussel M; Institut Universitaire du Cancer de Toulouse-Oncopole and Centre de Recherches en Cancerologie de Toulouse Institut National de la Sante et de la Recherche Medicale, Toulouse., Benboubker L; Centre Hospitalier Regional Universitaire Tours, Tours., Eveillard JR; Centre Hospitalier Universitaire de Brest, Brest., Dib M; Centre Hospitalier Universitaire Angers, Angers., Divoux M; Centre Hospitalier Regional Universitaire Nancy Vandoeuvre les Nancy, Nancy., Attal M; Institut Universitaire du Cancer de Toulouse-Oncopole and Centre de Recherches en Cancerologie de Toulouse Institut National de la Sante et de la Recherche Medicale, Toulouse., Avet-Loiseau H; Institut Universitaire du Cancer de Toulouse-Oncopole and Centre de Recherches en Cancerologie de Toulouse Institut National de la Sante et de la Recherche Medicale, Toulouse., Corre J; Institut Universitaire du Cancer de Toulouse-Oncopole and Centre de Recherches en Cancerologie de Toulouse Institut National de la Sante et de la Recherche Medicale, Toulouse. corre.jill@iuctoncopole.Fr.
Publikováno v:
Haematologica [Haematologica] 2023 May 01; Vol. 108 (5), pp. 1374-1384. Date of Electronic Publication: 2023 May 01.
Autor:
Lannes R; Myeloma Oncogenesis Lab, IUC-Oncopole, Toulouse, France.; CRCT, INSERM U1037, Toulouse, France., Samur M; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Perrot A; CRCT, INSERM U1037, Toulouse, France.; Hematology Department, IUC-Oncopole, Toulouse, France., Mazzotti C; Myeloma Oncogenesis Lab, IUC-Oncopole, Toulouse, France.; CRCT, INSERM U1037, Toulouse, France., Divoux M; Hematology Department, University Hospital, Nancy, France., Cazaubiel T; Hematology Department, University Hospital, Bordeaux, France., Leleu X; Hematology Department, University Hospital, Poitiers, France., Schavgoulidze A; Myeloma Oncogenesis Lab, IUC-Oncopole, Toulouse, France.; CRCT, INSERM U1037, Toulouse, France., Chretien ML; Hematology Department, University Hospital, Dijon, France., Manier S; Hematology Department, University Hospital, Lille, France., Adiko D; Hematology Department, General Hospital, Libourne, France., Orsini-Piocelle F; Hematology Department, General Hospital, Annecy, France., Lifermann F; Hematology Department, General Hospital, Dax, France., Brechignac S; Hematology Department, University Hospital, Bobigny, France., Gastaud L; Hematology Department, Centre Lacassagne, Nice, France., Bouscary D; Hematology Department, Cochin University Hospital, Paris, France., Macro M; Hematology Department, University Hospital, Caen, France., Cleynen A; Institut Montpellierain Alexander Grothendieck, CNRS, Montpellier University, Montpellier, France., Mohty M; Hematology Department, Saint-Antoine University Hospital, Paris, France., Munshi N; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Corre J; Myeloma Oncogenesis Lab, IUC-Oncopole, Toulouse, France.; CRCT, INSERM U1037, Toulouse, France., Avet-Loiseau H; Myeloma Oncogenesis Lab, IUC-Oncopole, Toulouse, France.; CRCT, INSERM U1037, Toulouse, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Mar 20; Vol. 41 (9), pp. 1695-1702. Date of Electronic Publication: 2022 Nov 07.
Autor:
Schavgoulidze A; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France., Talbot A; Hematology Department, Saint-Louis University Hospital, University of Paris, Assistance Publique-Hôpitaux de Paris, Paris, France., Perrot A; Hematology Department, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse, France., Cazaubiel T; Hematology Department, Bordeaux University Hospital, Bordeaux, France., Leleu X; Hematology Department, Poitiers University Hospital, Poitiers, France., Manier S; Hematology Department, Lille University Hospital, Lille, France., Buisson L; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France., Mahéo S; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France., Do Souto Ferreira L; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France., Pavageau L; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France., Hulin C; Hematology Department, Bordeaux University Hospital, Bordeaux, France., Marolleau JP; Hematology Department, Amiens University Hospital, Amiens, France., Voillat L; Hematology Department, Chalon-sur-Saône Hospital, Chalon-sur-Saône, France., Belhadj K; Hematology Department, Créteil University Hospital, Créteil, France., Divoux M; Hematology Department, Nancy University Hospital, Nancy, France., Slama B; Hematology Department, Avignon Hospital, Avignon, France., Brechignac S; Hematology Department, Bobigny University Hospital, Bobigny, France., Macro M; Hematology Department, Caen University Hospital, Caen, France., Stoppa AM; Hematology Department, Institut Paoli Calmettes, Marseille, France., Sanhes L; Hematology Department, Perpignan Hospital, Perpignan, France., Orsini-Piocelle F; Hematology Department, Annecy Hospital, Annecy, France., Fontan J; Hematology Department, Besançon University Hospital, Besançon, France., Chretien ML; Hematology Department, Dijon University Hospital, Dijon, France., Demarquette H; Hematology Department, Dunkerque Hospital, Dunkerque, France., Mohty M; Hematology Department, Saint-Antoine University Hospital, Paris, France., Avet-Loiseau H; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France., Corre J; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France.
Publikováno v:
Blood [Blood] 2023 Mar 16; Vol. 141 (11), pp. 1308-1315.
Autor:
Heraudet L; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Galtier J; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Favre S; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Peyraud F; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Cazaubiel T; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Leroy H; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Mottal N; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Gros FX; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Forcade E; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Clément L; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Dumas PY; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Pigneux A; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France., Leguay T; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France.
Publikováno v:
British journal of haematology [Br J Haematol] 2022 Aug; Vol. 198 (3), pp. 523-527. Date of Electronic Publication: 2022 May 07.
Autor:
Cazaubiel T; Department of Hematology, University Hospital, Bordeaux, France.; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France., Leleu X; Department of Hematology, University Hospital, Poitiers, France., Perrot A; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.; Department of Hematology, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Manier S; Department of Hematology, University Hospital, Lille, France., Buisson L; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Maheo S; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Do Souto Ferreira L; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Lannes R; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France.; Bioinformatics Department, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA., Pavageau L; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Hulin C; Department of Hematology, University Hospital, Bordeaux, France., Marolleau JP; Department of Hematology, University Hospital, Amiens, France., Voillat L; Department of Hematology, Hospital, Chalon-sur-Saône, France., Belhadj K; Department of Hematology, University Hospital, Créteil, France., Divoux M; Department of Hematology, University Hospital, Nancy, France., Slama B; Department of Hematology, Hospital, Avignon, France., Brechignac S; Department of Hematology, University Hospital, Bobigny, France., Macro M; Department of Hematology, University Hospital, Caen, France., Stoppa AM; Department of Hematology, Institut Paoli Calmettes, Marseille, France., Sanhes L; Department of Hematology, Hospital, Perpignan, France., Orsini-Piocelle F; Department of Hematology, Hospital, Annecy, France., Fontan J; Department of Hematology, University Hospital, Besançon, France., Chretien ML; Department of Hematology, University Hospital, Dijon, France., Demarquette H; Department of Hematology, Hospital, Dunkerque, France; and., Mohty M; Department of Hematology, Saint-Antoine University Hospital, Paris, France., Schavgoulidze A; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Avet-Loiseau H; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Corre J; Team Genomic and Immunology of Multiple Myeloma, Centre de Recherche en Cancérologie de Toulouse INSERM U1037, Paul Sabatier University, Toulouse, France.; Myeloma Oncogenesis Laboratory, Institut Universitaire du Cancer-Oncopole, Toulouse, France.
Publikováno v:
Blood [Blood] 2022 Apr 28; Vol. 139 (17), pp. 2666-2672.
Autor:
Schavgoulidze A; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche, Médicale U1037, 31059 Toulouse, France., Cazaubiel T; Hematology Department, University Hospital, 33600 Bordeaux, France., Perrot A; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche, Médicale U1037, 31059 Toulouse, France.; Hematology Department, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, 31059 Toulouse, France., Avet-Loiseau H; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche, Médicale U1037, 31059 Toulouse, France.; Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, 31059 Toulouse, France., Corre J; Centre de Recherche en Cancérologie de Toulouse, Institut National de la Santé et de la Recherche, Médicale U1037, 31059 Toulouse, France.; Unit for Genomics in Myeloma, Institut Universitaire du Cancer de Toulouse-Oncopole, University Hospital, 31059 Toulouse, France.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Mar 13; Vol. 13 (6). Date of Electronic Publication: 2021 Mar 13.
Autor:
Jung, Jongheon1 (AUTHOR), Jung, Sung-Hoon2 (AUTHOR), Lee, Je-Jung2 (AUTHOR), Do, Young Rok3 (AUTHOR), Kang, Ka-Won4 (AUTHOR), Lee, Jung Lim5 (AUTHOR), Yoon, Sung-Soo6 (AUTHOR), Min, Chang-Ki7 (AUTHOR), Kang, Hye Jin8 (AUTHOR), Lee, Ji Hyun9 (AUTHOR), Park, Ju-Hyun10 (AUTHOR), Kim, Kihyun11 (AUTHOR) kihyunkimk@gmail.com, Eom, Hyeon-Seok1 (AUTHOR) hseom@ncc.re.kr
Publikováno v:
Scientific Reports. 10/17/2024, Vol. 14 Issue 1, p1-14. 14p.